137 related articles for article (PubMed ID: 25467776)
1. Inter- and intra-lesional molecular heterogeneity of oral leukoplakia.
Gomes CC; Fonseca-Silva T; Galvão CF; Friedman E; De Marco L; Gomez RS
Oral Oncol; 2015 Feb; 51(2):178-81. PubMed ID: 25467776
[TBL] [Abstract][Full Text] [Related]
2. Molecular screening of oral precancer.
Graveland AP; Bremmer JF; de Maaker M; Brink A; Cobussen P; Zwart M; Braakhuis BJ; Bloemena E; van der Waal I; Leemans CR; Brakenhoff RH
Oral Oncol; 2013 Dec; 49(12):1129-35. PubMed ID: 24120275
[TBL] [Abstract][Full Text] [Related]
3. Association between histopathological features of dysplasia in oral leukoplakia and loss of heterozygosity.
Fonseca-Silva T; Diniz MG; de Sousa SF; Gomez RS; Gomes CC
Histopathology; 2016 Feb; 68(3):456-60. PubMed ID: 26042642
[TBL] [Abstract][Full Text] [Related]
4. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.
Xia RH; Song XM; Wang XJ; Li J; Mao L
PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase 3 contributes to malignant transformation of oral leukoplakia to cancer.
Wu X; Wang R; Jiao J; Li S; Yu J; Yin Z; Zhou L; Gong Z
Int J Biochem Cell Biol; 2018 Nov; 104():34-42. PubMed ID: 30172723
[TBL] [Abstract][Full Text] [Related]
6. Relationship between microRNA expression levels and histopathological features of dysplasia in oral leukoplakia.
Brito JA; Gomes CC; Guimarães AL; Campos K; Gomez RS
J Oral Pathol Med; 2014 Mar; 43(3):211-6. PubMed ID: 24020903
[TBL] [Abstract][Full Text] [Related]
7. Snail and Axin2 expression predict the malignant transformation of oral leukoplakia.
Zhang X; Kim KY; Zheng Z; Kim HS; Cha IH; Yook JI
Oral Oncol; 2017 Oct; 73():48-55. PubMed ID: 28939076
[TBL] [Abstract][Full Text] [Related]
8. Progressive increase of human papillomavirus carriage rates in potentially malignant and malignant oral disorders with increasing malignant potential.
Szarka K; Tar I; Fehér E; Gáll T; Kis A; Tóth ED; Boda R; Márton I; Gergely L
Oral Microbiol Immunol; 2009 Aug; 24(4):314-8. PubMed ID: 19572894
[TBL] [Abstract][Full Text] [Related]
9. Expression of p16 in oral cancer and premalignant lesions.
Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
[TBL] [Abstract][Full Text] [Related]
10. Accumulative increase of loss of heterozygosity from leukoplakia to foci of early cancerization in leukoplakia of the oral cavity.
Jiang WW; Fujii H; Shirai T; Mega H; Takagi M
Cancer; 2001 Nov; 92(9):2349-56. PubMed ID: 11745290
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of oral lichen planus. A premalignant lesion?
Zhang L; Michelsen C; Cheng X; Zeng T; Priddy R; Rosin MP
Am J Pathol; 1997 Aug; 151(2):323-7. PubMed ID: 9250145
[TBL] [Abstract][Full Text] [Related]
12. Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management.
Zhang L; Cheung KJ; Lam WL; Cheng X; Poh C; Priddy R; Epstein J; Le ND; Rosin MP
Cancer; 2001 Jun; 91(11):2148-55. PubMed ID: 11391596
[TBL] [Abstract][Full Text] [Related]
13. Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia: molecular evidence of incomplete resection.
Zhang L; Poh CF; Lam WL; Epstein JB; Cheng X; Zhang X; Priddy R; Lovas J; Le ND; Rosin MP
Oral Oncol; 2001 Sep; 37(6):505-12. PubMed ID: 11435177
[TBL] [Abstract][Full Text] [Related]
14. Malignant transformation of Taiwanese patients with oral leukoplakia: A nationwide population-based retrospective cohort study.
Wang TY; Chiu YW; Chen YT; Wang YH; Yu HC; Yu CH; Chang YC
J Formos Med Assoc; 2018 May; 117(5):374-380. PubMed ID: 29428194
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
16. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory.
Dionne KR; Warnakulasuriya S; Zain RB; Cheong SC
Int J Cancer; 2015 Feb; 136(3):503-15. PubMed ID: 24482244
[TBL] [Abstract][Full Text] [Related]
17. 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites.
Rosin MP; Lam WL; Poh C; Le ND; Li RJ; Zeng T; Priddy R; Zhang L
Cancer Res; 2002 Nov; 62(22):6447-50. PubMed ID: 12438233
[TBL] [Abstract][Full Text] [Related]
18. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
[TBL] [Abstract][Full Text] [Related]
19. DNA content status using brush biopsy with image cytometry correlated with staging of oral leukoplakia: a preliminary study.
Xiao X; Shi L; Li H; Song Y; Liu W; Zhou Z
Oral Oncol; 2015 Jan; 51(1):59-63. PubMed ID: 25459158
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity: a potential tool in management of oral premalignant lesions?
Zhang L; Rosin MP
J Oral Pathol Med; 2001 Oct; 30(9):513-20. PubMed ID: 11555152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
